Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$11.5 - $17.96 $284,199 - $443,845
-24,713 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$10.62 - $13.12 $23,650 - $29,218
-2,227 Reduced 8.27%
24,713 $287,000
Q1 2020

May 15, 2020

SELL
$8.38 - $17.34 $9.74 Million - $20.2 Million
-1,162,253 Reduced 97.73%
26,940 $280,000
Q4 2019

Feb 14, 2020

BUY
$11.18 - $18.6 $8.32 Million - $13.8 Million
743,871 Added 167.04%
1,189,193 $21.3 Million
Q3 2019

Nov 14, 2019

SELL
$12.09 - $20.46 $1.44 Million - $2.44 Million
-119,020 Reduced 21.09%
445,322 $5.56 Million
Q2 2019

Aug 13, 2019

BUY
$18.5 - $25.47 $2.27 Million - $3.12 Million
122,491 Added 27.72%
564,342 $11.2 Million
Q1 2019

May 17, 2019

SELL
$14.62 - $22.13 $168,363 - $254,849
-11,516 Reduced 2.54%
441,851 $9.31 Million
Q4 2018

Feb 14, 2019

SELL
$17.09 - $38.25 $1.21 Million - $2.71 Million
-70,901 Reduced 13.52%
453,367 $9.26 Million
Q3 2018

Oct 30, 2018

SELL
$34.05 - $55.9 $2.44 Million - $4.01 Million
-71,797 Reduced 12.05%
524,268 $19.3 Million
Q2 2018

Jul 31, 2018

BUY
$36.15 - $52.5 $23,497 - $34,125
650 Added 0.11%
596,065 $30 Million
Q1 2018

Apr 30, 2018

BUY
$24.4 - $40.25 $1.49 Million - $2.46 Million
61,104 Added 11.44%
595,415 $21.7 Million
Q4 2017

Jan 31, 2018

SELL
$18.5 - $28.6 $549,949 - $850,192
-29,727 Reduced 5.27%
534,311 $15.1 Million
Q3 2017

Nov 06, 2017

BUY
$14.65 - $19.35 $8.26 Million - $10.9 Million
564,038
564,038 $10.9 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $749M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.